Congress and Physician Independence in 2026: Two Bills, Two Approaches
For most of the past decade, the story of physician practice ownership has moved in one direction. Independent practices sold to hospitals, health systems, insurers, and private equity-backed platforms, and physicians became employees. Orthopedics, spine, pain management, and anesthesiology have been among the most active specialties for these transactions. In 2026, Congress is paying attention in a way it has not before. Committees held hearings on consolidation. Physician members of Congress introduced a bipartisan bill to overhaul Medicare physician payment, arguing that underpayment drives doctors to sell. And in September, a group of Democratic lawmakers introduced legislation to ban the corporate practice of medicine nationwide and restrict the management services organizations that private equity uses to control practices. This pillar article explains what is happening in Congress, the two main legislative approaches, the arguments on each side, and what pain, orthopedic, and spine practices should watch.
The scale of consolidation
Recent data frame the debate. Research by the Physicians Advocacy Institute and Avalere Health found that more than 82 percent of physicians were employed by hospitals or corporate entities as of January 2026, and that hospitals and corporate entities owned 63.9 percent of physician practices, with corporate ownership, including private equity, insurers, and other non-physician owners, accounting for 33.2 percent. The same research found that 152,200 fewer physicians were operating independently in January 2026 than in 2018, and that corporate entities acquired more than 52,000 physician practices between 2018 and 2026.
Private equity is a smaller share of the total than its visibility suggests. A Government Accountability Office review found that about 6.5 percent of physicians worked in private equity-owned practices in 2024, compared with at least 47 percent employed by or affiliated with hospital systems. But private equity has been concentrated in certain specialties, including several relevant to MSK care, and its growth rate drew attention.
Recent market data also show a slowdown. Private equity health care deals fell 18.5 percent in the second quarter of 2026 compared with a year earlier, with deals in physician practice management and multispecialty groups on pace for about half their 2025 levels. Analysts cited economic factors and increased state regulatory scrutiny.
Why practices sell
Witnesses at a March 2026 House hearing on health care costs, including representatives of the American Medical Association, the American Academy of Family Physicians, and a large employer purchaser group, agreed that increasing government reimbursement for physicians would help practices remain independent. The AMA’s board chair described physicians as in crisis over payment, with costs for insurance, rent, and staff rising sharply.
The payment gap is measurable. According to the AMA, Medicare reimbursement for physician services, adjusted for inflation, declined 33 percent from 2001 to 2026. Physicians received a temporary 2.5 percent increase for 2026, but the proposed 2027 fee schedule would reduce the conversion factor by 1.68 percent for most physicians as that temporary increase expires.
Other factors cited by physicians and policy analysts include:
- Site-of-service payment differences. Medicare often pays more for the same outpatient service in a hospital outpatient department than in a physician office, which rewards hospital acquisition of practices. CMS has taken limited steps toward site neutrality, including in its 2026 outpatient payment rule, but large differences remain.
- Administrative burden. Prior authorization, quality reporting, algorithmic claim review, and complex billing rules require staff and technology that small practices struggle to afford.
- Capital needs. Imaging, ASCs, EHRs, cybersecurity, and AI tools require investment.
- Succession. Senior physicians often need a buyer to realize the value of practices they built.
Approach 1: Restrict who can own and control practices
On September 16, 2026, Senators Elizabeth Warren, Ron Wyden, and Jeff Merkley, and Representatives Val Hoyle, Alexandria Ocasio-Cortez, and Suhas Subramanyam introduced the Stop Corporate Takeovers of Physicians Act of 2026. The bill is modeled on Oregon’s 2025 corporate practice of medicine law.
Under the bill, it would generally be unlawful for a partnership or corporate entity that is not majority-owned and controlled by licensed health professionals to own or control a medical practice, employ a licensed health professional, or engage in the practice of medicine. The bill would also:
- Prohibit management services organizations from controlling a practice through a “friendly” or “captive” physician, or by taking over functions such as hiring and firing, work schedules, compensation, disbursement of revenue or setting revenue targets, billing practices, and contracting.
- Require physician owners to be meaningfully engaged in providing medical care in the state where the practice is located.
- Prohibit corporate interference with clinical decisions.
- Ban restrictive contract terms, including non-compete, nondisclosure, and non-disparagement agreements.
Supporters include the American Academy of Emergency Medicine and the American Economic Liberties Project. They argue that corporate ownership, particularly private equity with leveraged buyout financing, pressures physicians to change care delivery, raises prices, and has contributed to practice bankruptcies, and that state corporate practice laws have been circumvented through MSO structures.
Critics and skeptics raise several concerns. Commentators have noted that the bill would create a national framework in an area historically regulated by states, raising questions about federal-state interaction. Investors and some physicians argue that outside capital helps practices afford technology, expand access, and give retiring physicians a path to sell. Others ask how the bill would apply to existing arrangements, hospital employment, and legitimate management services. Opponents are also likely to argue that restricting private capital could push more practices toward hospital systems, which already employ far more physicians than private equity.
The bill was introduced by Democratic members. Its prospects in the current Congress are uncertain, and a separate article in this cluster examines its provisions in detail.
Approach 2: Pay independent practices enough to stay independent
A different approach focuses on Medicare payment. In July 2026, Representatives John Joyce, MD (R-PA), Greg Murphy, MD (R-NC), and Kim Schrier, MD (D-WA), with 23 original cosponsors, introduced the Patients First Act (H.R. 9693), a bipartisan proposal to reform the Medicare physician payment system. The AMA and many physician organizations support it.
Key provisions include:
- Inflation-based updates. Replacing the current fixed updates with annual updates tied to the Medicare Economic Index, which measures the cost of running a practice, with a floor of 25 percent of MEI and a ceiling of 75 percent of MEI.
- Budget neutrality reform. Raising the threshold that triggers across-the-board budget neutrality cuts to $57.64 million in 2028, indexed to MEI every five years, adding corrections when CMS overestimates utilization of new codes, updating practice cost inputs every five years, and limiting year-to-year swings in the conversion factor to 2.5 percent.
- Alternative payment models. Freezing participation thresholds for three years, requiring notice and comment before CMS implements or substantially changes mandatory Innovation Center models, and directing a report on barriers to specialist participation.
- Quality reporting. Replacing current reporting with a simplified system.
A related bill introduced earlier, the Provider Reimbursement Stability Act, focuses on the budget neutrality reforms.
Supporters argue that stable, inflation-adjusted payment would remove a major driver of consolidation and that budget neutrality rules have produced repeated cuts. The Medicare Payment Advisory Commission has recommended an inflation-based update, although at MEI minus one percentage point.
Critics focus on cost. The Committee for a Responsible Federal Budget noted that such proposals would add meaningfully to deficits without offsets, and estimated that MedPAC’s own recommendation would cost about $25 billion through 2035. Others question whether payment increases alone would reverse consolidation driven by other factors.
Other levers in play
- Site-neutral payment. Proposals to equalize Medicare payment across settings would reduce the financial advantage of hospital ownership. Hospitals oppose broad site-neutral policies, arguing that they have higher costs and obligations.
- State action. States have enacted and proposed laws requiring advance notice of health care transactions, strengthening corporate practice doctrines, and restricting private equity. Oregon’s 2025 law is the most prominent. Rhode Island requires notice for certain mergers producing groups of at least eight clinicians.
- Antitrust enforcement. Federal and state antitrust agencies have scrutinized serial acquisitions in physician specialties.
- Transparency. Proposals would require disclosure of practice ownership.
2026 at a glance
| When | Development |
|---|---|
| January 2026 | Temporary 2.5 percent Medicare physician payment increase takes effect for the year |
| March 2026 | House hearing examines provider consolidation and health care costs |
| March 2026 | Provider Reimbursement Stability Act introduced to reform budget neutrality |
| Second quarter 2026 | Private equity health care deal volume falls compared with 2025 |
| July 2026 | Patients First Act (H.R. 9693) introduced with bipartisan sponsors |
| July 2026 | CY 2027 physician fee schedule proposed, with a conversion factor reduction for most physicians |
| September 2026 | Stop Corporate Takeovers of Physicians Act introduced |
| November 2026 (expected) | CY 2027 physician fee schedule final rule |
How MSK specialties have been affected
Orthopedics, spine, pain management, and anesthesiology have been attractive to investors for several reasons: high procedure volume, ancillary and ASC revenue, fragmented markets with many small groups, and an aging population with growing musculoskeletal needs. Platforms built by acquiring multiple groups in a region have become common. Hospitals have also acquired orthopedic and spine practices to secure surgical volume for their operating rooms.
For physicians in these specialties, the consequences vary. Some report better access to capital, technology, and administrative support after joining a platform. Others report reduced autonomy, pressure on productivity, compensation changes after an initial period, and restrictive covenants that limit their options. Research from the Commonwealth Fund, based on interviews with physicians and advisers, found that outcomes depend heavily on deal terms, including compensation structures, governance rights, and non-compete provisions. That is why both legislative approaches matter to MSK physicians: one would change the rules for such deals, and the other would change the economics that drive them.
Questions physician owners are asking
Should we sell now before rules change? Decisions about selling should rest on the practice’s long-term goals and a careful review of terms, not on speculation about legislation. Regulatory uncertainty is a factor to weigh, not a reason to rush.
Could existing arrangements be unwound? Proposals differ on how they would treat existing arrangements. Oregon’s law phased in over several years. Any federal law would depend on its final text. Review agreements with counsel now so you understand your position.
Will payment reform pass? Physician payment reform has broad support among physician organizations and bipartisan sponsors, but cost is a significant obstacle. Plan for 2027 assuming the proposed cut, with upside if Congress acts.
How can we make our views known? Specialty societies and state medical associations coordinate advocacy on both payment reform and ownership legislation. Legislators pay most attention to concrete local examples, such as a practice that closed a location, stopped accepting new Medicare patients, or sold because of payment pressures, or conversely a practice that improved access after an investment.
Does any of this change our day-to-day operations now? Not directly. Neither bill is law. But the issues they address, payment adequacy and physician control, are worth acting on now through better revenue cycle performance and careful review of management agreements. Practices that act on these issues now will be better positioned whatever Congress ultimately does, and they will have better information for any decision about their future, including whether to stay independent, partner with others, or sell to a larger organization on favorable terms.
What this means for MSK practices
For independent pain, orthopedic, and spine practices, the policy debate matters in several ways:
- Payment. If Medicare payment reform passes, independent practices would have more predictable revenue. If it does not, the pressure to consolidate continues, especially with the proposed 2027 cut.
- Transactions. Practices considering a sale should expect more regulatory review, possible state notice requirements, and deal terms shaped by uncertainty about federal and state restrictions.
- MSO relationships. Practices using management companies should review whether their agreements leave clinical and key business decisions with physicians. This is good practice regardless of legislation, and it is where federal and state proposals focus.
- Mandatory models. The Patients First Act’s notice-and-comment provision would affect how CMS launches models like the Ambulatory Specialty Model, which begins January 1, 2027, for many low back pain specialists.
- Operational excellence. Whatever Congress does, independent practices remain independent by running efficient revenue cycles, controlling costs, and adapting to payer and regulatory change.
What to watch
- Whether the Stop Corporate Takeovers of Physicians Act gains cosponsors, especially bipartisan ones, or hearings.
- Whether the Patients First Act or budget neutrality reforms move through committees or become part of a larger legislative package.
- The CY 2027 physician fee schedule final rule, expected in November, and any congressional response to the proposed cut.
- State legislation in the 2027 sessions.
- Transaction volume and deal structures in MSK specialties.
Operational takeaway
Congress is debating physician independence through two very different lenses. One approach, reflected in the Stop Corporate Takeovers of Physicians Act, would restrict who can own and control medical practices and limit the MSO structures used by private equity and other corporate investors. The other, reflected in the bipartisan Patients First Act, would reform Medicare physician payment so that independent practices can afford to stay independent. Each has supporters and critics, and neither is law. For MSK practice owners, the practical response is the same regardless of outcome: understand the proposals, review ownership and management arrangements with counsel, strengthen the revenue cycle and cost structure, and make decisions about independence based on sound operations rather than pressure.
About the author
References
- Office of Senator Elizabeth Warren and co-sponsors. Press release introducing the Stop Corporate Takeovers of Physicians Act, September 2026.
- American Medical Association. Bill Would Put an End to Yearly Patches on Medicare Physician Pay (Patients First Act, H.R. 9693), September 2026, and National Advocacy Update, July 31, 2026.
- Physicians Advocacy Institute and Avalere Health. Physician employment and practice ownership research, 2026.
- Fierce Healthcare. To Tackle Healthcare Costs, Representatives Weigh Curbs on Provider Consolidation, March 2026.
- Committee for a Responsible Federal Budget. The Next Doc Fix Is Coming, May 2026.
- Medscape. States Tighten Private Equity Healthcare Oversight as Deals Slow, 2026.
This article is educational, reflects legislative status as of September 2026, and does not advocate for or against any legislation.
